Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRAME family member 31, pseudogene (PRAMEF31P), is annotated as a **pseudogene** of the PRAME (Preferentially expressed Antigen in Melanoma) gene family[1]. Pseudogenes are genetic sequences similar to known genes but generally lack the capacity to encode functional proteins, either due to mutations, truncations, or lack of regulatory elements. While the functional PRAME protein is implicated in cellular processes such as meiosis, DNA repair, and chromosomal stability—and is associated with various cancers[2][3][5]—**PRAMEF31P itself is not known to have a direct biological function, disease association, or therapeutic relevance**. It is best classified as a non-coding genomic sequence rather than a protein-coding target or receptor. **Notes:** - PRAMEF31P is not a functional protein or receptor. - It is not a therapeutic target. - There is no evidence for clinical, mechanistic, or biomarker roles for PRAMEF31P itself[1]. - All functions and disease associations are relevant to the PRAME family in general, not to this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRAME family member 31, pseudogene (PRAMEF31P).